495 related articles for article (PubMed ID: 23625163)
1. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
3. The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women.
Streb J; Glanowska I; Streb A; Szpor J; Kryka K; Potocki P; Wójcik M; Jach R
Neuro Endocrinol Lett; 2017 Dec; 38(6):437-440. PubMed ID: 29298285
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.
Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW
Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676
[TBL] [Abstract][Full Text] [Related]
5. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Hu K; Callen DF; Li J; Zheng H
Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D and hypertension in premenopausal and postmenopausal women: National Health and Nutrition Examination Surveys 2007-2010.
Kwak JH; Hong YC; Choi YH
Public Health Nutr; 2020 May; 23(7):1236-1246. PubMed ID: 31948509
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
8. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
Abbas S; Chang-Claude J; Linseisen J
Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
11. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
12. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE
Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.
Yao S; Sucheston LE; Millen AE; Johnson CS; Trump DL; Nesline MK; Davis W; Hong CC; McCann SE; Hwang H; Kulkarni S; Edge SB; O'Connor TL; Ambrosone CB
PLoS One; 2011 Feb; 6(2):e17251. PubMed ID: 21386992
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.
Kühn T; Kaaks R; Becker S; Eomois PP; Clavel-Chapelon F; Kvaskoff M; Dossus L; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Lukanova A; Buijsse B; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Krogh V; Sacerdote C; Tumino R; Mattiello A; Buckland G; Sánchez MJ; Menéndez V; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; van Duijnhoven FJ; van Gils CH; Bakker MF; Weiderpass E; Skeie G; Brustad M; Andersson A; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Rinaldi S; Romieu I; Gallo V; Murphy N; Riboli E; Linseisen J
Int J Cancer; 2013 Oct; 133(7):1689-700. PubMed ID: 23526380
[TBL] [Abstract][Full Text] [Related]
16. Association between plasma 25-hydroxyvitamin D and breast cancer risk.
Crew KD; Gammon MD; Steck SE; Hershman DL; Cremers S; Dworakowski E; Shane E; Terry MB; Desai M; Teitelbaum SL; Neugut AI; Santella RM
Cancer Prev Res (Phila); 2009 Jun; 2(6):598-604. PubMed ID: 19470790
[TBL] [Abstract][Full Text] [Related]
17. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.
Chen GC; Zhang ZL; Wan Z; Wang L; Weber P; Eggersdorfer M; Qin LQ; Zhang W
Cancer Causes Control; 2015 Dec; 26(12):1719-28. PubMed ID: 26358829
[TBL] [Abstract][Full Text] [Related]
18. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
19. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
[TBL] [Abstract][Full Text] [Related]
20. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies.
Chen Y; Liu L; Zhou Q; Imam MU; Cai J; Wang Y; Qi M; Sun P; Ping Z; Fu X
BMC Public Health; 2017 Dec; 17(1):936. PubMed ID: 29216920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
